International Conference on Current Trends in Drug Development and Industrial Pharmacy
ICCTDDIP
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest advancements in drug discovery methodologies and technologies. Participants will explore novel approaches that enhance the efficiency and efficacy of identifying potential therapeutic agents.
SDG 3
SDG 4
This session will delve into contemporary practices in industrial pharmacy, emphasizing the integration of technology and regulatory compliance. Discussions will include case studies highlighting successful implementations in pharmaceutical manufacturing.
SDG 9
This track addresses the critical aspects of pharmacovigilance, including risk assessment and management strategies. Experts will discuss the importance of post-marketing surveillance in ensuring drug safety and efficacy.
SDG 3
SDG 9
This session will cover the intricacies of designing and conducting clinical trials, focusing on regulatory requirements and ethical considerations. Participants will gain insights into best practices for trial management and data integrity.
SDG 3
SDG 4
This track highlights recent developments in medicinal chemistry, including the design and synthesis of novel compounds. Discussions will focus on the role of medicinal chemistry in enhancing drug efficacy and reducing side effects.
SDG 3
SDG 9
This session will explore cutting-edge technologies and methodologies in laboratory medicine. Participants will discuss the impact of these innovations on diagnostics and patient care.
SDG 3
SDG 9
This track examines the complexities of supply chain management within the pharmaceutical industry. Key topics will include logistics, inventory control, and strategies for ensuring product availability.
SDG 12
This session will focus on sustainable waste management practices in pharmaceutical manufacturing. Participants will discuss regulatory compliance and innovative strategies for minimizing environmental impact.
SDG 12
SDG 13
This track emphasizes the importance of quality assurance and good manufacturing practices in the pharmaceutical industry. Experts will share insights on maintaining compliance and ensuring product quality throughout the manufacturing process.
SDG 3
SDG 9
This session will address the critical role of drug information in patient education and adherence. Participants will explore effective communication strategies to enhance patient understanding of medications.
SDG 3
SDG 4
This track will cover the intricacies of patent applications and the drug registration process. Experts will discuss the implications of intellectual property on drug development and market access.
SDG 9
SDG 16